NetworkNewsBreaks – EVIO, Inc. (EVIO) Preparing for Increased Demand as California’s July 1 Testing Deadline Approaches
EVIO, Inc. (OTCQB: EVIO), a leading provider of cannabis testing and scientific research for the regulated cannabis industry, this morning detailed its recent expansion to meet increased cannabis testing demand following California’s July 1 testing deadline. The regulations set forth by California’s Bureau of Cannabis Control state that, beginning July 1, a licensed retailer may only sell cannabis goods that have met all state-mandated testing requirements. Among EVIO’s efforts, the company’s EVIO Labs Berkeley facility is in the process of becoming ISO 17025 accredited – the highest recognized quality standard in the world for calibration and testing laboratories. “The new regulations state that untested cannabis products cannot be sold by a retailer and must be destroyed, which poses great economic threat to both producers and dispensaries that have not prepared. Because of this, EVIO has been laser focused on expanding our footprint in the state to increase our capacity for more analyses,” Lori Glauser, COO of EVIO, stated in the news release. “As the cannabis industry continues to transition from the black market into the light, EVIO is both well-prepared and committed to ensuring that consumers are receiving clean and safe products.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
EVIO, Inc. (OTCQB: EVIO), a leading provider of cannabis testing and scientific research for the regulated cannabis industry, this morning detailed its recent expansion to meet increased cannabis testing demand following California’s July 1 testing deadline. The regulations set forth by California’s Bureau of Cannabis Control state that, beginning July 1, a licensed retailer may only sell cannabis goods that have met all state-mandated testing requirements. Among EVIO’s efforts, the company’s EVIO Labs Berkeley facility is in the process of becoming ISO 17025 accredited – the highest recognized quality standard in the world for calibration and testing laboratories. “The new regulations state that untested cannabis products cannot be sold by a retailer and must be destroyed, which poses great economic threat to both producers and dispensaries that have not prepared. Because of this, EVIO has been laser focused on expanding our footprint in the state to increase our capacity for more analyses,” Lori Glauser, COO of EVIO, stated in the news release. “As the cannabis industry continues to transition from the black market into the light, EVIO is both well-prepared and committed to ensuring that consumers are receiving clean and safe products.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
